Research on the biological activity and anti-tumor effect against lymphoma cells of DC-CIK cells

Chinese-German Journal of Clinical Oncology

Volumn 7, Issue 11, 2008, Pages 666-669

  Wei, Xucang ^a   Zhai, Xinhui ^a   Zhao, Wenli ^b   Yang, Didi ^a   Han, Xiurui ^a  

^a SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Anti lymphoma; Biological activity; Cytokine induced killer cells (CIK); Dendriti ccells cytokine induced killer cells (DC CIK)

Indexed keywords

EID: 56449097759     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-008-0084-1     Document Type: Article

References (10)

1. Yamaguchi Y, Ohshita A, Kawabuchi Y, et al. Adoptive immunotherapy of cancer using activated autologous lymphocytes - current status and new strategies. Hum Cell, 2003, 16: 183-189.
2. Zhou CJ, Ma W, Zhou JD, et al. Killing activity of cytotoxic T lymphocytes stimulated by dendritic cell vaccine loaded with autologous cervical cancer antigen. Chin J Cancer (Chinese), 2006, 25: 143-147.
3. + monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination. Br J Haematol, 2003, 121: 240-250.
4. Wei XC, Xing PN, Zhao WL, et al. The experimental study of the biological activity and anti-tumor effects of CD3AK cells in human umbilical cord blood. J Xi'an Jiaotong Univ (Med Sci) (Chinese), 2005, 26: 52-54.
5. Wang FS, Liu MX, Zhang B, et al. Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma in vitro and in vivo. World J Gastroenterol, 2002, 8: 464-468.
6. Linn YC, Hui KM. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia. Leuk Lymphoma, 2003, 44: 1457-1462.
7. Märten A, Schöttker B, Ziske C, et al. Increase of the immnostimulatory effect of dendritic cells by pulsing with CA 19-9 protein. J Immunother, 2000, 23: 464-472.
8. Hackstein H, Thomson AW. Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol, 2004, 4: 24-34.
9. + cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma. Cancer Immunol Immunother, 2004, 53: 1018-1026.
10. Fujii S, Shimizu K, Kronenberg M, et al. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol, 2002, 3: 867-874.